Search
Musk's venture, Neuralink, aims to decipher silent "thought speech" by 2025 and progressively increase the number of chip electrodes annually, with a vision of achieving deep integration with AI by 2028 to explore treatments for mental illnesses and beyond. The company has introduced three products tailored for patients with movement disorders, visual impairments, and neurological diseases. Presently, the seven participants use the device for an average of 50 hours each week. Neuralink has successfully executed the world's first human brain-computer interface implant trial and, following its latest funding round, boasts a valuation exceeding $10 billion. Looking ahead, the company's brain-computer interface technology could enable humans to directly control humanoid robots.
-
C114 Communication Network -
Communication Home
